Ash Stevens wins MichBio award; Sigma-Aldrich targets South Korea with API deal

> Drugmaker Ash Stevens, which is undertaking a $12 million expansion at its plant in  Riverview, MI, has been selected by MichBio to receive this year's Good to Great Award which recognizes the "leap forward" the company has made under the leadership of CEO Stephen A. Munk. Here's the letter.

> Italy's Menarini is committing to a $1 billion deal with Oxford BioTherapeutics to develop and manufacture a slate of new armed antibodies aimed at cancer targets. Story

> Dr. Reddy's Laboratories Tuesday reported a 32% jump in second quarter profit propelled by its generics manufacturing and sales in the U.S. Story

> Sigma-Aldrich ($SIAL) said it is moving into the growing South Korea market after its custom manufacturing and services unit struck a deal with CrystalGenomics to provide active pharmaceutical ingredients (APIs) for the company's next-generation non-steroidal anti-inflammatory drugs. Release 

> AMSilk said it has validated large-scale production validation of large-scale production of its recombinant spider silk proteins, which can be used in pharmaceuticals, showing it can produce its Spidersilk product on the metric ton scale. Release

> A report from research firm Visiongain forecasts the market for products related to fighting counterfeit pharmaceuticals will hit $1.2 billion by 2015, mostly for RFID and 2D barcoding technologies. Release 

And finally.... A film crew for the Brad Pit post apocalyptic war movie "World War Z," has been doing some scene reshoots in a former Pfizer Viagra plant in Sandwich, U.K. Story

Suggested Articles

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.

Boehringer Ingelheim is investing $50 million in an animal health plant in Puerto Rico, adding 105 jobs.

Teva will begin producing chemo drug vincristine in the U.S. but has resisted the idea that its withdrawal from the market led to a shortage.